William Blair Comments on 908 Devices Inc.’s Q1 2025 Earnings (NASDAQ:MASS)

908 Devices Inc. (NASDAQ:MASSFree Report) – Equities research analysts at William Blair issued their Q1 2025 earnings per share estimates for 908 Devices in a research note issued on Tuesday, April 30th. William Blair analyst M. Larew forecasts that the company will post earnings of ($0.35) per share for the quarter. The consensus estimate for 908 Devices’ current full-year earnings is ($1.27) per share. William Blair also issued estimates for 908 Devices’ Q2 2025 earnings at ($0.29) EPS, Q3 2025 earnings at ($0.23) EPS and Q4 2025 earnings at ($0.19) EPS.

908 Devices (NASDAQ:MASSGet Free Report) last issued its quarterly earnings data on Tuesday, April 30th. The company reported ($0.33) EPS for the quarter, topping analysts’ consensus estimates of ($0.36) by $0.03. The company had revenue of $9.99 million for the quarter, compared to analysts’ expectations of $9.29 million. 908 Devices had a negative return on equity of 20.47% and a negative net margin of 68.57%. The firm’s quarterly revenue was up 5.3% on a year-over-year basis. During the same quarter in the previous year, the firm posted ($0.39) earnings per share.

908 Devices Stock Performance

Shares of NASDAQ MASS opened at $5.67 on Thursday. 908 Devices has a 1 year low of $4.85 and a 1 year high of $12.51. The firm has a market cap of $187.00 million, a price-to-earnings ratio of -5.30 and a beta of 1.02. The stock’s 50-day simple moving average is $6.57 and its 200-day simple moving average is $7.07.

Institutional Trading of 908 Devices

A number of hedge funds and other institutional investors have recently modified their holdings of MASS. Values First Advisors Inc. increased its position in shares of 908 Devices by 24.5% during the third quarter. Values First Advisors Inc. now owns 16,726 shares of the company’s stock worth $111,000 after acquiring an additional 3,294 shares during the last quarter. SG Americas Securities LLC purchased a new stake in shares of 908 Devices during the fourth quarter worth about $133,000. Arete Wealth Advisors LLC increased its position in shares of 908 Devices by 35.8% during the third quarter. Arete Wealth Advisors LLC now owns 22,758 shares of the company’s stock worth $152,000 after acquiring an additional 5,997 shares during the last quarter. New York State Common Retirement Fund increased its position in shares of 908 Devices by 15.3% during the third quarter. New York State Common Retirement Fund now owns 70,525 shares of the company’s stock worth $470,000 after acquiring an additional 9,346 shares during the last quarter. Finally, Bank of New York Mellon Corp increased its position in shares of 908 Devices by 11.1% during the third quarter. Bank of New York Mellon Corp now owns 93,775 shares of the company’s stock worth $625,000 after acquiring an additional 9,393 shares during the last quarter. 88.06% of the stock is owned by hedge funds and other institutional investors.

About 908 Devices

(Get Free Report)

908 Devices Inc, a commercial-stage technology company, provides various purpose-built handheld and desktop mass spectrometry devices to interrogate unknown and invisible materials in life sciences research, bioprocessing, pharma/biopharma, forensics, and adjacent markets. The company's products include MX908, a handheld, battery-powered, and Mass Spec device that is designed for rapid analysis of solid, liquid, vapor, and aerosol materials of unknown identity; Rebel, a small desktop analyzer that provides real-time information on the extracellular environment in bioprocesses; and Maverick, an optical in-line analyzer that offers real-time monitoring and control of multiple bioprocess parameters, including glucose, lactate, and total biomass in mammalian cell cultures, as well as provides process fingerprint data to support large-scale efforts in predictive bioprocess modeling.

See Also

Earnings History and Estimates for 908 Devices (NASDAQ:MASS)

Receive News & Ratings for 908 Devices Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for 908 Devices and related companies with MarketBeat.com's FREE daily email newsletter.